You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科學委員會:未曾染疫18至59歲成人若有較高暴露風險或個人需要 可選擇打第四針
阿思達克 05-20 12:16
衛生署衛生防護中心轄下聯合科學委員會昨日(19日)聯同行政長官專家顧問團進行網上會議,討論本港18至59歲成人接種第四劑新冠疫苗的事宜,並於今日(20日)發表更新的暫擬共識建議。 經審視最新科學實證和本地情況,專家認爲現時接種新冠疫苗的目標爲預防因感染新冠肺炎而出現的重症和死亡。本地數據顯示接種三劑復必泰疫苗或克爾來福疫苗對預防重症和死亡高度有效,其保護力一般可於數個月內維持高水平。 專家認爲接種第四劑新冠疫苗或能對較年輕的成年人提供短暫的額外保護,以預防感染和出現病徵。未曾受感染的18至59歲的成人若有較高暴露風險或個人需要(如到海外升學或爲符合到海外旅遊的規定等),經考慮對自身的風險和益處後,可選擇接種第四劑新冠疫苗,惟須與第三劑相距最少6個月,而相同的做法亦可適用於同一年齡組別的康復者。 另一方面,由於60歲或以上人士於本地第五波疫情死亡個案中佔大多數,專家於上月已建議他們接種第四劑新冠疫苗。 聯合科學委員會聯同專家顧問團重申,整體人口完成接種所建議的劑數,以建立免疫屏障來預防新冠肺炎引致的重症和死亡,對應付未來的疫情十分重要。專家們會繼續密切留意新的科學實證,以就接種額外疫苗的劑數作出建議。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account